Hyperprogression to a dual immune blockade followed by subsequent response with cabozantinib in metastatic poor-risk clear cell renal cell carcinoma with NOTCH mutation

  1. Molina-Cerrillo, J.
  2. Alonso-Gordoa, T.
  3. Carrato, A.
  4. Grande, E.
Journal:
Oncotarget

ISSN: 1949-2553

Year of publication: 2020

Volume: 11

Issue: 22

Pages: 2137-2140

Type: Article

DOI: 10.18632/ONCOTARGET.27598 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus